Open Access
- 1 January 2011
- journal article
- review article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 9 (1) , 85
Abstract
Aromatase inhibitors have been introduced as a new treatment modality that could challenge clomiphene citrate as an ovulation induction regiment in patients with PCOS. Although several randomized trials have been conducted regarding their use as ovulation induction agents, only few trials are available regarding their efficacy in IVF stimulated cycles. Current available evidence support that letrozole may have a promising role in stimulated IVF cycles, either when administered during the follicular phase for ovarian stimulation. Especially for women with poor ovarian response, letrozole appears to have the potential to increase clinical pregnancy rates when combined with gonadotropins, whereas at the same time reduces the total gonadotropin dose required for ovarian stimulation. However, given that in all of the trials letrozole has been administered in GnRH antagonist cycles, it is intriguing to test in the future how it may perform when used in GnRH agonist cycles. Finally administration of letrozole during luteal phase in IVF cycles offers another treatment modality for patients at high risk for OHSS taking into account that it drastically reduces estradiol levelsKeywords
This publication has 24 references indexed in Scilit:
- Aromatase inhibitors for female infertility: a systematic review of the literatureReproductive BioMedicine Online, 2009
- Letrozole in ovulation induction: time to make decisionsHuman Reproduction Update, 2008
- Treatment of Unexplained Infertility With Aromatase Inhibitors or Clomiphene CitrateObstetrical & Gynecological Survey, 2008
- Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era?Fertility and Sterility, 2008
- Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysisJNCI: Journal of the National Cancer Institute, 2006
- Aromatase Inhibitors for Ovulation InductionThe Journal of Clinical Endocrinology & Metabolism, 2006
- Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot studyReproductive BioMedicine Online, 2006
- The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatmentReproductive Biology and Endocrinology, 2005
- The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: A pilot studyFertility and Sterility, 2005
- A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary reportHuman Reproduction, 2004